JEFFREY NARD: Open Payments
NPI 1184612426 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,719 in 73 payments from 21 companies in 2025. Trend: 2023 $1,204 · 2024 $1,537 · 2025 $1,719
Food & beverage: $1,719
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 8 | $197 |
| Axsome Therapeutics, Inc. | 7 | $171 |
| Neurocrine BioSciences, Inc. | 6 | $151 |
| ACADIA Pharmaceuticals Inc | 3 | $148 |
| Vanda Pharmaceuticals Inc. | 5 | $138 |
| ABBVIE INC. | 5 | $102 |
| Janssen Pharmaceuticals, Inc | 4 | $95 |
| Bausch Health US, LLC | 5 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $84 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
Products named: Azstarys, INGREZZA, NUPLAZID, Auvelity, FANAPT, APLENZIN, CAPLYTA, VRAYLAR.
Industry payments across FL — which companies pay providers there.
